ArticleJCO precision oncology2026

Evaluating Tumor Burden as a Predictive Biomarker for Epidermal Growth Factor Receptor Targeted Kinase Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer.

Rika Terashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.